• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 4. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

Introduction to 6-Fluoro-2-phenyl-1H-indole (CAS No. 255724-72-2)

6-Fluoro-2-phenyl-1H-indole, identified by its Chemical Abstracts Service (CAS) number 255724-72-2, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the indole family, characterized by a bicyclic structure consisting of a benzene ring fused to a pyrrole ring. The presence of a fluoro substituent at the 6-position and a phenyl group at the 2-position imparts unique electronic and steric properties, making it a valuable scaffold for the development of bioactive molecules.

The fluoro group, a well-documented pharmacophore in drug design, contributes to the lipophilicity and metabolic stability of the molecule. Its electron-withdrawing nature can modulate the reactivity of adjacent functional groups, influencing both binding affinity and pharmacokinetic profiles. In contrast, the phenyl group introduces additional steric hindrance and potential hydrogen bonding interactions, which can be exploited to enhance binding specificity to biological targets.

Recent advancements in computational chemistry and structure-based drug design have highlighted the importance of indole derivatives in addressing various therapeutic challenges. The 6-fluoro-2-phenyl-1H-indole scaffold has been extensively explored for its potential in modulating enzyme activity and receptor interactions. For instance, studies have demonstrated its utility in inhibiting cyclin-dependent kinases (CDKs), which are implicated in cell cycle regulation and cancer progression. The fluoro substitution enhances the binding affinity to these kinases by optimizing hydrogen bonding networks and hydrophobic interactions.

In addition to its applications in oncology, 6-fluoro-2-phenyl-1H-indole has shown promise in neurodegenerative disease research. Emerging evidence suggests that indole derivatives can interact with amyloid-beta plaques, a hallmark of Alzheimer's disease, by forming stable complexes that disrupt aggregation. The fluoro and phenyl substituents play critical roles in this interaction, modulating the compound's ability to penetrate the blood-brain barrier and exert neuroprotective effects.

The synthesis of 6-fluoro-2-phenyl-1H-indole typically involves multi-step organic transformations, including fluorination reactions, phenylation, and cyclization processes. Advanced synthetic methodologies such as transition metal-catalyzed cross-coupling reactions have been employed to improve yield and purity. These techniques align with the growing emphasis on green chemistry principles, ensuring sustainable production practices that minimize waste and hazardous byproducts.

From a medicinal chemistry perspective, the versatility of 6-fluoro-2-phenyl-1H-indole as a scaffold allows for structural modifications that can fine-tune its biological activity. Functional groups such as amides, ethers, or alcohols can be introduced at various positions to enhance solubility or target specific enzymes. For example, derivatives with hydroxyl groups have been found to exhibit enhanced binding to estrogen receptors, making them relevant for breast cancer therapy.

The pharmacokinetic profile of 6-fluoro-2-phenyl-1H-indole is another critical consideration in drug development. Preclinical studies have indicated that this compound exhibits moderate oral bioavailability and prolonged half-life due to its metabolic stability conferred by the fluoro substituent. Further investigations are underway to optimize dosing regimens and minimize potential side effects, ensuring safe and effective therapeutic use.

Emerging research also explores the role of 6-fluoro-2-phenyl-1H-indole in infectious disease treatment. Its structural features make it a promising candidate for inhibiting bacterial enzymes such as DNA gyrase or topoisomerase IV, which are essential for bacterial replication. By targeting these enzymes specifically, indole derivatives like this one could offer novel strategies against antibiotic-resistant pathogens.

The regulatory landscape for 6-fluoro-2-phenyl-1H-indole is evolving in tandem with advancements in drug development technologies. Regulatory agencies now emphasize innovative approaches such as structure-based design and biomarker-driven trials to expedite approval processes. This shift has facilitated faster translation of laboratory findings into clinical applications, benefiting patients with unmet medical needs.

In conclusion,6-fluoro-2-phenyl-1H-indole (CAS No. 255724-72-2) represents a compelling example of how structural modifications can enhance biological activity and therapeutic potential. Its unique combination of electronic and steric properties makes it a versatile scaffold for addressing diverse diseases ranging from cancer to neurodegenerative disorders. As research continues to uncover new applications for this compound, 6-fluoro - 2 - phenyl - 1 H - indole is poised to play an increasingly significant role in future drug discovery efforts.

• 109883-55-8(Quinoline, 4-fluoro-2-phenyl-)
• 58861-55-5(Quinoline, 2-(3-fluorophenyl)-)
• 50971-14-7(Quinoline, 2-(4-fluorophenyl)-6-methyl-)
• 782-17-2(2-(4-fluorophenyl)-1H-indole)
• 59541-83-2(5-fluoro-2-phenyl-1H-indole)
• 159788-74-6(Quinoline, 4-fluoro-2-(2-naphthalenyl)-)
• 76609-18-2(2-(4-fluorophenyl)-5-methyl-1H-Indole)
• 323-91-1(Quinoline, 2-(4-fluorophenyl)-)
• 68290-36-8(2-(3,4-Difluorophenyl)indole)
• 52765-22-7(2-(2-Fluorophenyl)-1H-indole)